Kosmidis P, Kalofonos H, Christodoulou C, Syrigos K, Makatsoris T, Skarlos D, et al. Paclitaxel and gemcitabine versus carboplatin and gemcitabine in patients with advanced non-small-cell lung cancer. A phase III study of the Hellenic Cooperative Oncology Group. Ann Oncol. 2008;19:115-22 pubmed
..However, statistically significant differences were seen in toxicity. The two regimens are equally active. Myelotoxicity is worse in the CG group whereas alopecia, myalgia and neurotoxicity worse in the PG group. ..